Green Competitors

Stocks . Korea . 
Stock . Green Cross Medical
142280 Stock  KRW 3,660  85.00  2.27%   
Green Cross Medical competes with Samsung Card, EBEST Investment, Koh Young, Hansol Chemica, and COWAY; as well as few others. Analyzing Green Cross competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Green Cross to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Green Cross Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Green Cross competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
3,6583,6603,662
Details
Intrinsic
Valuation
LowRealHigh
3,2303,2324,026
Details
Naive
Forecast
LowNextHigh
3,7163,7193,721
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3,4583,8814,305
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Green Cross. Your research has to be compared to or analyzed against Green Cross' peers to derive any actionable benefits. When done correctly, Green Cross' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Green Cross Medical.

Green Cross Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Green Cross and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Green and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Green Cross Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
014680
+ 0.89
098460
014680
+ 0.88
078020
047810
+ 0.86
003530
098460
+ 0.84
078020
016360
+ 0.69
086790
105560
+ 0.55
047810
  
High negative correlations   
047810
- 0.72
021240
047810
- 0.72
098460
047810
- 0.67
014680
003530
- 0.65
098460
047810
- 0.65
078020
003530
- 0.62
021240

Risk-Adjusted Indicators

There is a big difference between Green Stock performing well and Green Cross Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Green Cross' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
029780  1.32  0.00 (0.05) 0.13  1.84 
(1.40)
 2.49 
(2.67)
 12.28 
078020  0.97 (0.37) 0.00 (1.52) 0.00 
 0.00 
 1.84 
(2.54)
 7.02 
098460  1.79 (0.40) 0.00  1.79  0.00 
 0.00 
 3.45 
(4.44)
 11.81 
014680  2.04 (0.51) 0.00  1.27  0.00 
 0.00 
 4.31 
(3.79)
 12.39 
021240  1.57  0.02 (0.03) 0.19  2.17 
(1.68)
 3.75 
(3.37)
 12.77 
003530  2.28 (0.08)(0.03) 0.04  2.66 
(2.73)
 4.94 
(4.27)
 25.75 
086790  1.66 (0.10) 0.00 (0.28) 0.00 
 0.00 
 4.07 
(4.07)
 9.86 
047810  1.79  0.05 (0.01) 0.27  1.97 
(2.29)
 4.18 
(3.15)
 13.23 
016360  1.16  0.01 (0.06)(0.13) 1.82 
(1.15)
 2.62 
(2.78)
 9.15 
105560  1.94  0.20  0.03 (12.27) 2.25 
(2.09)
 4.74 
(3.91)
 13.12 
All Fundamental Data

Green Cross Competitive Analysis

The better you understand Green Cross competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Green Cross' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Green Cross' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
142280 029780 078020 098460 014680 021240 003530 086790 047810 016360
 2.27 
 3,660 
Green
 1.61 
 42,700 
Samsung
 3.54 
 3,955 
EBEST
 2.95 
 8,220 
Koh
 1.58 
 99,900 
Hansol
 3.37 
 65,900 
COWAY
 1.14 
 3,535 
Hanwha
 2.35 
 62,400 
Hana
 2.99 
 58,400 
Korea
 0.63 
 47,600 
Samsung
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Insignificant
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.6
N/A
2.45
5.09
N/A
N/A
N/A
N/A
N/A
N/A
Net Asset
95.63 B
27.14 T
6.93 T
368.33 B
1.2 T
3.8 T
11.79 T
502.45 T
5.86 T
65.71 T
Profit Margin
0.0664
82.12
0.1
0.2
0.16
0.12
0.0302
0.3
0.0477
0.0467
EBITDA
8.84 B
N/A
N/A
55.32 B
257.17 B
1.2 T
N/A
N/A
226.54 B
N/A
Operating Margin
0.0468
-219.03
0.41
0.16
0.22
0.17
0.28
0.53
0.0336
0.2
Current Valuation
272.85 B
17.55 T
(813.51 B)
1.31 T
2.38 T
5.38 T
136.7 B
(5.52 T)
5.21 T
(552.65 B)
Price To Book
N/A
0.44
N/A
N/A
3.11
1.91
0.36
0.37
3.36
0.51
Retained Earnings
N/A
N/A
184.12 B
111.29 B
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
3.52 T
131.8 B
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.81
0.36
0.84
1.02
1.09
0.83
1.6
1.0
0.66
0.92
Number Of Employees
138
10
20
459
543
6.55 K
1.03 K
10
36
10
Shares Outstanding
9.62 M
106.71 M
51.06 M
13.12 M
10.88 M
72.56 M
213.87 M
291.56 M
97.48 M
89.3 M
Cash Flow From Operations
(18.2 B)
(2.59 T)
(171.23 B)
42.48 B
143.22 B
331.29 B
(1.11 T)
(24.25 T)
439.96 B
(2.07 T)
Annual Yield
N/A
0.0804
0.0816
0.0069
0.0108
0.022
0.0815
0.0686
0.004
0.0497
Total Debt
6.16 B
N/A
1.23 T
26.19 B
198.56 B
456.36 B
N/A
N/A
1.1 T
N/A
Return On Equity
-42.94
0.0771
7.5
0.18
0.2
0.23
0.0347
0.11
0.0884
0.0916
Z Score
5.8
N/A
N/A
4.8
6.6
5.4
N/A
N/A
2.4
N/A
Return On Asset
0.0313
0.0208
0.0236
0.0706
0.1
0.0998
0.0046
0.0068
0.0098
0.0085
Current Liabilities
N/A
N/A
1.26 T
29.11 B
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
95.63 B
27.14 T
6.93 T
368.33 B
1.2 T
3.8 T
11.79 T
502.45 T
5.86 T
65.71 T
Debt To Equity
169.6
N/A
3.48
2.2
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
37750.0
N/A
19400.0
303082.0
81308.0
N/A
60192.0
69667.0
45444.0
Last Dividend Paid
N/A
2500.0
N/A
N/A
2100.0
1250.0
200.0
3350.0
200.0
1700.0
Shares Owned By Institutions
0.19
75.53
62.92
59.82
57.91
55.49
55.48
52.5
51.28
47.63
Market Capitalization
51.07 B
3.29 T
256.81 B
225.25 B
2.3 T
4.14 T
691.87 B
14.29 T
4.78 T
2.96 T
Price To Earning
N/A
N/A
7.06
22.28
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.22
N/A
N/A
Price To Sales
0.66
486.82
0.17
0.68
2.45
1.08
0.3
1.07
1.71
0.26
Net Income
(21.14 B)
551.06 B
160.83 B
39.59 B
148.34 B
465.66 B
144.11 B
3.53 T
63.9 B
965.34 B
Earnings Per Share
N/A
753.63
N/A
N/A
3002.39
1444.99
N/A
2969.77
320.89
1037.0
Shares Owned By Insiders
55.16
N/A
2.1
20.85
17.66
25.09
1.09
1.04
1.54
0.23
Revenue
101.67 B
2.69 T
1.24 T
247.3 B
768.69 B
3.66 T
508.78 B
10.86 T
2.56 T
2.25 T
Working Capital
N/A
N/A
2.26 T
102.69 B
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
1.84 B
N/A
34.63 B
67.49 B
N/A
N/A
N/A
N/A
N/A
N/A
Cash Per Share
236.44
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
19.78 B
(1.17 T)
1.89 T
157.11 B
267.14 B
2.38 T
1.7 T
9.96 T
263.26 B
8.33 T
Day Typical Price
3695.0
42900.0
4011.67
8306.67
100133.0
66633.33
3530.0
62766.67
59066.67
47483.33
Accumulation Distribution
0.0279
0.023
0.0412
0.0399
0.0439
0.0466
0.0321
0.0204
0.0428
0.0157
Market Facilitation Index
105.0
1000.0
170.0
340.0
4500.0
3200.0
115.0
1300.0
2600.0
750.0
Daily Balance Of Power
(0.81)
(0.70)
(0.85)
(0.74)
(0.36)
(0.72)
0.3478
(1.15)
(0.69)
0.4
Period Momentum Indicator
(85.00)
(700.00)
(145.00)
(250.00)
(1,600)
(2,300)
40.0
(1,500)
(1,800)
300.0
Rate Of Daily Change
0.98
0.98
0.96
0.97
0.98
0.97
1.01
0.98
0.97
1.01
Day Median Price
3712.5
43000.0
4040.0
8350.0
100250.0
67000.0
3527.5
62950.0
59400.0
47425.0
Price Action Indicator
(95.00)
(650.00)
(157.50)
(255.00)
(1,150)
(2,250)
27.5
(1,300)
(1,900)
325.0
Coefficient Of Variation
(442.85)
4623.65
(397.10)
(554.37)
(457.43)
3479.37
7239.13
(3,955)
2270.7
9864.5
Mean Deviation
1.9
1.32
0.9696
1.79
2.04
1.57
2.28
1.66
1.79
1.16
Jensen Alpha
(0.57)
(0.0004)
(0.37)
(0.40)
(0.51)
0.0176
(0.08)
(0.1)
0.0507
0.0135
Total Risk Alpha
(1.02)
(0.28)
(0.56)
(0.83)
(0.99)
(0.32)
(0.54)
(0.44)
(0.30)
(0.27)
Sortino Ratio
N/A
(0.05)
N/A
N/A
N/A
(0.03)
(0.03)
N/A
(0.01)
(0.06)
Downside Variance
N/A
3.9
N/A
N/A
N/A
5.43
7.76
N/A
5.04
3.7
Standard Deviation
2.57
1.88
1.31
2.35
2.54
2.24
3.43
2.24
2.38
1.65
Kurtosis
1.14
2.67
0.9106
0.6074
0.1918
2.77
9.15
0.6495
0.99
3.03
Potential Upside
3.79
2.49
1.84
3.45
4.31
3.75
4.94
4.07
4.18
2.62
Treynor Ratio
4.25
0.126
(1.52)
1.79
1.27
0.1885
0.0395
(0.28)
0.2736
(0.13)
Maximum Drawdown
12.65
12.28
7.02
11.81
12.39
12.77
25.75
9.86
13.23
9.15
Variance
6.59
3.52
1.71
5.52
6.47
5.01
11.76
5.01
5.68
2.72
Market Risk Adjusted Performance
4.26
0.136
(1.51)
1.8
1.28
0.1985
0.0495
(0.27)
0.2836
(0.12)
Risk Adjusted Performance
(0.17)
0.0225
(0.19)
(0.13)
(0.16)
0.0286
0.0183
(0.01)
0.0405
0.0131
Skewness
(0.35)
0.0298
(0.37)
(0.21)
0.6413
(0.10)
1.79
(0.14)
0.4583
(0.95)
Semi Deviation
N/A
1.84
N/A
N/A
N/A
2.17
2.66
N/A
1.97
1.82
Information Ratio
(0.28)
(0.05)
(0.36)
(0.24)
(0.27)
(0.03)
(0.03)
(0.09)
(0.01)
(0.07)
Value At Risk
(5.43)
(2.67)
(2.54)
(4.44)
(3.79)
(3.37)
(4.27)
(4.07)
(3.15)
(2.78)
Expected Short fall
N/A
(1.40)
N/A
N/A
N/A
(1.68)
(2.73)
N/A
(2.29)
(1.15)
Downside Deviation
N/A
1.97
N/A
N/A
N/A
2.33
2.79
N/A
2.24
1.92
Semi Variance
N/A
3.38
N/A
N/A
N/A
4.7
7.08
N/A
3.87
3.32

Green Cross Competition Performance Charts

Five steps to successful analysis of Green Cross Competition

Green Cross' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Green Cross Medical in relation to its competition. Green Cross' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Green Cross in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Green Cross' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Green Cross Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Green Cross position

In addition to having Green Cross in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Real Estate theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Green Stock

Green Cross financial ratios help investors to determine whether Green Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Green with respect to the benefits of owning Green Cross security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY